Brian Tyser’s Post

Thoughts on this? >> After two patient deaths from presumed sepsis, FDA puts partial hold on Zentalis studies >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #productmarketing #pharmaceutical #biotech

We realize that managing a serious diagnosis can be particularly challenging. At PFSP we provide support and education about your disease and treatment options. Our team offers support to patients every step of the way. https://bit.ly/3nGxF2N #pharmacy #speciatypharmacy

You know Lipitor, that innovator brand of Atorvastatin hailed as the best-selling drug since it was approved for use in 1996 in the US. Lipitor is used to treat dyslipidemia and prevent cardiovascular disease. In 2020, it was the most commonly prescribed medication in the United States, with more than 114 million prescriptions. Now, for a bit of trivia: can you pinpoint the year Lipitor's patent bid farewell, and just how much this statin medication amassed in its impressive journey? #RemedialHealth #TriviaThursday #Patent #Lipitor

I am so proud of each and every member of our dedicated team who has worked tirelessly to reach this important U.S. regulatory milestone on behalf of people living with chronic inflammatory demyelinating polyneuropathy (#CIDP). This approval is just one example of how we are working to improve the patient experience and further establish the value and versatility of plasma-derived therapies! #Plasma, #PlasmaDerivedTherapies, #RareDiseases

Here at K2 Scientific, we proudly play an important role in supporting critical healthcare advancements. with our cold-storage solutions and supporting technology. My personal journey as a blood donor, intensified by the current national blood shortage, recently took a new turn when I embraced plasma donation. My decision, spurred by our company's growth in the plasma sector, aimed to deepen my understanding of the operational intricacies and help foster innovation within our offerings. My experience at the plasma center was eye-opening, not just in terms of understanding the process, but also in realizing the profound impact of plasma donation. Each donation can be a lifeline, contributing to life-saving treatments and medical breakthroughs. The stories of individuals whose lives have been transformed by plasma-derived therapies were particularly inspiring. Takeda's recent FDA approval spotlights one such treatment. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a debilitating autoimmune disorder characterized by a gradual weakening and sensory loss in the arms and legs, compromised balance, and, in severe cases, an inability to walk. The approval of new plasma-based treatments marks a significant milestone in offering hope and improving the quality of life for those affected by this relentless disease. Despite the evident benefits, plasma donation is often shrouded in misconceptions and stigma, overshadowing its immense potential in driving scientific progress and medical innovation. The recent approval of Takeda's innovative therapy, a subcutaneous immunoglobulin treatment infused with hyaluronidase, exemplifies the groundbreaking advancements achievable through dedicated plasma donation. In light of this, perhaps you'll reconsider any hesitations about plasma donation. It's more than a simple act of giving; it's a powerful contribution to the betterment of global health. Let's recognize and celebrate the incredible work of companies like Takeda, and all of those who work in the industry in relentless pursuit of medical innovation. I'm inspired by the continuous push on the boundaries of health and wellness, not just in America but worldwide. Consider this an invitation to make a profound impact. Plasma donation is a testament to the strength of collective effort in forging a healthier, more resilient society. Together, let's embrace this opportunity to fuel scientific discovery and champion the cause of improved health and wellness for all. #medicalgradecoldstorage #healthcareinnovation #plasma #plasmaderivedtherapy #healthcareheroes #healthcareforall #healthandwellness #scienceandtechnology #lifesciences

Idiopathic pulmonary fibrosis (#IPF) prevalence is on the rise globally. There is currently no cure for IPF and only two FDA approved treatments. Our article details some of the current clinical trials being conducted for possible new treatments. Learn more: https://lnkd.in/gYXpZRc8 #LungHealth #PulmonaryFibrosis #Respiratory #IdiopathicPulmonaryFibrosis

Wegovy reduces heart attacks! Wegovy just became the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults. In a clinical trial of over 17,000 patients, the Wegovy group had a 20% reduction in cardiovascular events compared to placebo. Wegovy is just one of the 3,000 FDA approved drugs, imagine all of the additional diseases that could potentially benefit from those drugs. This is why Every Cure exists. To unlock the full potential of existing medicines to treat every disease and every patient possible. I’d love to hear your thoughts on this news and the potential of drug repurposing in the comments below. #drugdevelopment #wegovy #ozempic #drugrepurposing

From what I know Diabetes Type 2 can be reversed if the patient looses enough weight, so to me it seems that GLP-1 agonist drugs are enough. For more info, please read the article.

🚨 FDA ALERT: Rare but serious reactions linked to antiseizure medicines! The #USFDA cautions about potential life-threatening Drug Reactions with Eosinophilia and Systemic Symptoms (DRESS) from levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan). While hypersensitivity is rare, quick diagnosis and treatment are crucial. Symptoms may start as a rash but escalate, impacting internal organs and potentially leading to hospitalization or worse. FDA mandates updated warnings in prescribing info and patient guides. Stay informed, stay safe! #FDAAlert #DrugSafety